SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

C4 Therapeutics Q3'26 Earnings Preview

C4 Therapeutics is scheduled to report Q3'26 results on October 29, with EPS anticipated at $(0.20).

CCCC